CVRx (CVRX) Financials

$6.03 +0.09 (+1.52%)

As of 02:47 PM Eastern

Annual Income Statements for CVRx

This table shows CVRx's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024
Period end date	12/31/2022	12/31/2023	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	-41	-41	-60
Consolidated Net Income / (Loss)	-41	-41	-60
Net Income / (Loss) Continuing Operations	-41	-41	-60
Total Pre-Tax Income	-41	-41	-60
Total Operating Income	-43	-43	-59
Total Gross Profit	17	33	43
Total Revenue	22	39	51
Operating Revenue	22	39	51
Total Cost of Revenue	5.00	6.26	8.33
Operating Cost of Revenue	5.00	6.26	8.33
Total Operating Expenses	60	76	102
Selling, General & Admin Expense	50	65	91
Research & Development Expense	9.95	12	11
Total Other Income / (Expense), net	1.21	2.05	-0.42
Interest Expense	0.17	1.80	4.40
Other Income / (Expense), net	1.37	3.85	3.98
Income Tax Expense	0.11	0.15	0.06
Basic Earnings per Share	($2.02)	($1.99)	($2.65)
Weighted Average Basic Shares Outstanding	20.53M	20.75M	22.60M
Diluted Earnings per Share	($2.02)	($1.99)	($2.65)
Weighted Average Diluted Shares Outstanding	20.53M	20.75M	22.60M
Weighted Average Basic & Diluted Shares Outstanding	20.69M	20.93M	26.04M

This table shows CVRx's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	-9.83	-11	-11	-12	-9.01	-9.16	-22	-14	-13	-11
Consolidated Net Income / (Loss)	-9.83	-11	-11	-12	-9.01	-9.16	-22	-14	-13	-11
Net Income / (Loss) Continuing Operations	-9.83	-11	-11	-12	-9.01	-9.16	-22	-14	-13	-11
Total Pre-Tax Income	-9.80	-11	-11	-12	-8.97	-9.12	-22	-14	-13	-11
Total Operating Income	-10	-11	-12	-12	-9.53	-9.66	-22	-14	-13	-10
Total Gross Profit	4.85	5.67	6.65	7.98	8.82	9.59	9.16	9.91	11	13
Total Revenue	6.19	7.18	7.98	9.50	11	11	11	12	13	15
Operating Revenue	6.19	7.18	7.98	9.50	11	11	11	12	13	15
Total Cost of Revenue	1.34	1.51	1.33	1.52	1.69	1.72	1.62	1.90	2.25	2.57
Operating Cost of Revenue	1.34	1.51	1.33	1.52	1.69	1.72	1.62	1.90	2.25	2.57
Total Operating Expenses	15	17	19	20	18	19	31	24	24	23
Selling, General & Admin Expense	13	14	15	16	16	17	28	21	22	20
Research & Development Expense	2.29	3.05	3.42	3.28	2.70	2.24	3.06	2.77	2.50	2.81
Total Other Income / (Expense), net	0.33	0.97	0.82	0.14	0.56	0.54	0.08	-0.02	-0.04	-0.45
Interest Expense	0.00	0.17	0.24	0.48	0.50	0.58	0.96	0.96	0.96	1.52
Other Income / (Expense), net	0.33	1.14	1.06	0.62	1.06	1.12	1.04	0.94	0.92	1.07
Income Tax Expense	0.03	0.03	0.03	0.03	0.04	0.04	0.04	0.04	0.05	-0.07
Basic Earnings per Share	($0.48)	($0.51)	($0.55)	($0.56)	($0.43)	($0.45)	($1.04)	($0.65)	($0.57)	($0.39)
Weighted Average Basic Shares Outstanding	20.58M	20.53M	20.69M	20.71M	20.80M	20.75M	21.23M	21.63M	22.78M	22.60M
Diluted Earnings per Share	($0.48)	($0.51)	($0.55)	($0.56)	($0.43)	($0.45)	($1.04)	($0.65)	($0.57)	($0.39)
Weighted Average Diluted Shares Outstanding	20.58M	20.53M	20.69M	20.71M	20.80M	20.75M	21.23M	21.63M	22.78M	22.60M
Weighted Average Basic & Diluted Shares Outstanding	20.58M	20.69M	20.71M	20.76M	20.82M	20.93M	21.60M	21.79M	24.26M	26.04M

This table details how cash moves in and out of CVRx's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024
Period end date	12/31/2022	12/31/2023	12/31/2024
Net Change in Cash & Equivalents	-36	-16	15
Net Cash From Operating Activities	-43	-39	-39
Net Cash From Continuing Operating Activities	-43	-39	-39
Net Income / (Loss) Continuing Operations	-41	-41	-60
Consolidated Net Income / (Loss)	-41	-41	-60
Depreciation Expense	0.41	0.52	0.62
Amortization Expense	0.03	0.15	0.20
Non-Cash Adjustments To Reconcile Net Income	3.89	6.31	19
Changes in Operating Assets and Liabilities, net	-5.57	-4.81	0.95
Net Cash From Investing Activities	-0.69	-0.59	-1.36
Net Cash From Continuing Investing Activities	-0.69	-0.59	-1.36
Purchase of Property, Plant & Equipment	-0.69	-0.59	-1.36
Net Cash From Financing Activities	7.49	24	56
Net Cash From Continuing Financing Activities	7.49	24	56
Repayment of Debt	-0.78	-0.18	-0.15
Issuance of Debt	7.50	23	20
Issuance of Common Equity	0.59	0.94	33
Other Financing Activities, net	0.18	0.73	2.70
Effect of Exchange Rate Changes	-0.01	0.00	-0.00
Cash Interest Paid	0.06	1.40	3.61
Cash Income Taxes Paid	0.01	0.00	0.00

This table details how cash moves in and out of CVRx's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Net Change in Cash & Equivalents	-11	-3.79	-2.92	-12	-7.82	7.58	-10	-9.72	30	5.77
Net Cash From Operating Activities	-11	-11	-10	-13	-8.13	-7.84	-11	-9.83	-10	-8.01
Net Cash From Continuing Operating Activities	-11	-11	-10	-13	-8.13	-7.84	-11	-9.83	-10	-8.01
Net Income / (Loss) Continuing Operations	-9.83	-11	-11	-12	-9.01	-9.16	-22	-14	-13	-11
Consolidated Net Income / (Loss)	-9.83	-11	-11	-12	-9.01	-9.16	-22	-14	-13	-11
Depreciation Expense	0.13	0.13	0.13	0.13	0.14	0.13	0.13	0.14	0.17	0.18
Amortization Expense	-	0.03	0.03	0.04	0.04	0.04	0.05	0.05	0.05	0.06
Non-Cash Adjustments To Reconcile Net Income	0.93	1.07	1.71	1.48	1.53	1.59	11	2.54	2.68	2.69
Changes in Operating Assets and Liabilities, net	-2.32	-1.52	-0.74	-2.80	-0.82	-0.44	-0.03	1.47	-0.21	-0.28
Net Cash From Investing Activities	-0.26	-0.08	-0.24	-0.14	-0.04	-0.17	-0.92	-0.36	-0.04	-0.05
Net Cash From Continuing Investing Activities	-0.26	-0.08	-0.24	-0.14	-0.04	-0.17	-0.92	-0.36	-0.04	-0.05
Purchase of Property, Plant & Equipment	-0.26	-0.08	-0.24	-0.14	-0.04	-0.17	-0.92	-0.36	-0.04	-0.05
Net Cash From Financing Activities	0.01	7.12	7.57	0.47	0.36	16	1.36	0.47	40	14
Net Cash From Continuing Financing Activities	0.01	7.12	7.57	0.47	0.36	16	1.36	0.47	40	14
Repayment of Debt	-	-0.78	-0.06	-0.01	-	-0.11	0.00	-	-0.15	-0.00
Issuance of Common Equity	-	0.29	0.00	0.45	-	0.48	0.55	0.41	20	13
Other Financing Activities, net	0.01	0.10	0.13	0.03	0.36	0.21	0.82	0.07	0.73	1.09
Effect of Exchange Rate Changes	-0.01	0.01	0.00	0.02	-0.02	0.00	-0.00	-0.00	0.01	-0.00
Cash Interest Paid	-	0.06	0.19	0.38	0.42	0.42	0.77	0.84	0.84	1.16

This table presents CVRx's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024
Period end date	12/31/2022	12/31/2023	12/31/2024
Total Assets	125	115	133
Total Current Assets	123	112	130
Cash & Equivalents	106	91	106
Accounts Receivable	5.50	7.55	9.27
Inventories, net	6.96	11	12
Prepaid Expenses	4.22	2.99	2.51
Plant, Property, & Equipment, net	1.70	1.76	2.51
Total Noncurrent Assets	0.36	1.38	1.10
Other Noncurrent Operating Assets	0.36	1.38	1.10
Total Liabilities & Shareholders' Equity	125	115	133
Total Liabilities	16	39	62
Total Current Liabilities	8.09	7.86	11
Accounts Payable	1.72	1.88	2.58
Accrued Expenses	6.37	5.98	8.18
Total Noncurrent Liabilities	7.67	31	52
Long-Term Debt	6.75	29	49
Other Noncurrent Operating Liabilities	0.92	2.20	2.32
Commitments & Contingencies	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	109	76	71
Total Preferred & Common Equity	109	76	71
Total Common Equity	109	76	71
Common Stock	546	554	609
Retained Earnings	-436	-477	-537
Accumulated Other Comprehensive Income / (Loss)	-0.21	-0.21	-0.21

This table presents CVRx's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024
Period end date	9/30/2022	3/31/2023	6/30/2023	9/30/2023	3/31/2024	6/30/2024	9/30/2024
Total Assets	127	123	115	106	106	96	128
Total Current Assets	124	121	112	104	102	92	124
Cash & Equivalents	110	103	91	83	80	70	100
Accounts Receivable	5.30	6.43	6.73	6.37	8.50	8.61	9.03
Inventories, net	6.06	8.24	11	11	11	11	12
Prepaid Expenses	3.07	2.63	3.54	3.35	2.66	1.76	2.79
Plant, Property, & Equipment, net	1.75	1.81	1.82	1.72	2.55	2.76	2.63
Total Noncurrent Assets	0.42	0.30	1.14	1.08	1.30	1.23	1.17
Other Noncurrent Operating Assets	0.42	0.30	1.14	1.08	1.30	1.23	1.17
Total Liabilities & Shareholders' Equity	127	123	115	106	106	96	128
Total Liabilities	8.33	23	25	24	40	41	62
Total Current Liabilities	7.40	7.96	8.93	7.41	8.40	9.13	11
Accounts Payable	1.28	2.00	2.93	1.13	2.61	3.52	3.28
Accrued Expenses	6.12	5.96	5.99	6.27	5.79	5.61	7.67
Total Noncurrent Liabilities	0.94	15	16	16	32	32	52
Long-Term Debt	-	14	14	14	29	29	49
Other Noncurrent Operating Liabilities	0.94	0.87	1.83	1.88	2.24	2.29	2.33
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	118	100	90	83	66	55	65
Total Preferred & Common Equity	118	100	90	83	66	55	65
Total Common Equity	118	100	90	83	66	55	65
Common Stock	544	547	549	551	566	569	592
Retained Earnings	-426	-448	-459	-468	-500	-514	-527
Accumulated Other Comprehensive Income / (Loss)	-0.22	-0.20	-0.19	-0.21	-0.21	-0.21	-0.21

This table displays calculated financial ratios and metrics derived from CVRx's official financial filings.

Metric	2022	2023	2024
Period end date	12/31/2022	12/31/2023	12/31/2024
Growth Metrics	-	-	-
Revenue Growth	72.36%	74.89%	30.53%
EBITDA Growth	-0.86%	5.26%	-41.77%
EBIT Growth	-0.95%	4.62%	-41.42%
NOPAT Growth	-63.77%	-1.35%	-38.02%
Net Income Growth	3.83%	0.55%	-45.55%
EPS Growth	51.44%	1.49%	-33.17%
Operating Cash Flow Growth	-53.89%	8.57%	-0.32%
Free Cash Flow Firm Growth	-41.59%	1.62%	-18.26%
Invested Capital Growth	150.40%	50.01%	-1.40%
Revenue Q/Q Growth	18.56%	11.74%	8.54%
EBITDA Q/Q Growth	-0.30%	4.49%	-1.08%
EBIT Q/Q Growth	-0.47%	4.38%	-1.20%
NOPAT Q/Q Growth	-6.76%	4.05%	-1.04%
Net Income Q/Q Growth	0.08%	3.23%	-2.54%
EPS Q/Q Growth	-103.01%	2.93%	2.21%
Operating Cash Flow Q/Q Growth	-9.85%	7.14%	-0.43%
Free Cash Flow Firm Q/Q Growth	0.00%	6.10%	-0.28%
Invested Capital Q/Q Growth	17.85%	3.34%	1.12%
Profitability Metrics	-	-	-
Gross Margin	77.75%	84.08%	83.75%
EBITDA Margin	-181.21%	-98.17%	-106.63%
Operating Margin	-189.27%	-109.69%	-115.98%
EBIT Margin	-183.16%	-99.89%	-108.23%
Profit (Net Income) Margin	-184.38%	-104.85%	-116.91%
Tax Burden Percent	100.26%	100.36%	100.09%
Interest Burden Percent	100.40%	104.58%	107.92%
Effective Tax Rate	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	-437.14%	-247.99%	-287.24%
ROIC Less NNEP Spread (ROIC-NNEP)	-427.48%	-234.28%	-256.19%
Return on Net Nonoperating Assets (RNNOA)	404.66%	203.48%	205.66%
Return on Equity (ROE)	-32.47%	-44.51%	-81.58%
Cash Return on Invested Capital (CROIC)	-522.98%	-288.00%	-285.83%
Operating Return on Assets (OROA)	-29.66%	-32.69%	-44.65%
Return on Assets (ROA)	-29.86%	-34.31%	-48.23%
Return on Common Equity (ROCE)	-32.47%	-44.51%	-81.58%
Return on Equity Simple (ROE_SIMPLE)	-37.94%	-54.25%	-84.39%
Net Operating Profit after Tax (NOPAT)	-30	-30	-42
NOPAT Margin	-132.49%	-76.78%	-81.19%
Net Nonoperating Expense Percent (NNEP)	-9.65%	-13.72%	-31.05%
Return On Investment Capital (ROIC_SIMPLE)	-	-28.69%	-34.61%
Cost of Revenue to Revenue	22.25%	15.92%	16.25%
SG&A Expenses to Revenue	222.73%	164.17%	178.03%
R&D to Revenue	44.29%	29.60%	21.70%
Operating Expenses to Revenue	267.02%	193.77%	199.73%
Earnings before Interest and Taxes (EBIT)	-41	-39	-56
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-41	-39	-55
Valuation Ratios	-	-	-
Price to Book Value (P/BV)	3.46	8.62	4.33
Price to Tangible Book Value (P/TBV)	3.46	8.62	4.33
Price to Revenue (P/Rev)	16.81	16.65	5.99
Price to Earnings (P/E)	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	28.59	40.62	17.42
Enterprise Value to Revenue (EV/Rev)	12.38	15.09	4.89
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00
Leverage & Solvency	-	-	-
Debt to Equity	0.06	0.38	0.69
Long-Term Debt to Equity	0.06	0.38	0.69
Financial Leverage	-0.95	-0.87	-0.80
Leverage Ratio	1.09	1.30	1.69
Compound Leverage Factor	1.09	1.36	1.83
Debt to Total Capital	5.82%	27.79%	40.95%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	5.82%	27.79%	40.95%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%
Common Equity to Total Capital	94.18%	72.21%	59.05%
Debt to EBITDA	-0.17	-0.76	-0.90
Net Debt to EBITDA	2.44	1.59	1.04
Long-Term Debt to EBITDA	-0.17	-0.76	-0.90
Debt to NOPAT	-0.23	-0.97	-1.18
Net Debt to NOPAT	3.34	2.03	1.36
Long-Term Debt to NOPAT	-0.23	-0.97	-1.18
Altman Z-Score	9.69	4.50	-2.60
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-
Current Ratio	15.19	14.25	12.06
Quick Ratio	13.81	12.48	10.70
Cash Flow Metrics	-	-	-
Free Cash Flow to Firm (FCFF)	-36	-35	-41
Operating Cash Flow to CapEx	-6,230.22%	-6,602.54%	-2,876.12%
Free Cash Flow to Firm to Interest Expense	-215.85	-19.48	-9.42
Operating Cash Flow to Interest Expense	-258.65	-21.69	-8.90
Operating Cash Flow Less CapEx to Interest Expense	-262.80	-22.02	-9.21
Efficiency Ratios	-	-	-
Asset Turnover	0.16	0.33	0.41
Accounts Receivable Turnover	5.57	6.02	6.10
Inventory Turnover	0.92	0.70	0.72
Fixed Asset Turnover	14.39	22.71	24.04
Accounts Payable Turnover	4.49	3.47	3.73
Days Sales Outstanding (DSO)	65.50	60.63	59.84
Days Inventory Outstanding (DIO)	395.63	523.35	505.63
Days Payable Outstanding (DPO)	81.37	105.11	97.80
Cash Conversion Cycle (CCC)	379.75	478.87	467.68
Capital & Investment Metrics	-	-	-
Invested Capital	9.73	15	14
Invested Capital Turnover	3.30	3.23	3.54
Increase / (Decrease) in Invested Capital	5.85	4.87	-0.21
Enterprise Value (EV)	278	593	251
Market Capitalization	378	654	307
Book Value per Share	$5.30	$3.65	$2.93
Tangible Book Value per Share	$5.30	$3.65	$2.93
Total Capital	116	105	120
Total Debt	6.75	29	49
Total Long-Term Debt	6.75	29	49
Net Debt	-99	-61	-57
Capital Expenditures (CapEx)	0.69	0.59	1.36
Debt-free, Cash-free Net Working Capital (DFCFNWC)	8.60	14	13
Debt-free Net Working Capital (DFNWC)	115	104	119
Net Working Capital (NWC)	115	104	119
Net Nonoperating Expense (NNE)	12	11	18
Net Nonoperating Obligations (NNO)	-99	-61	-57
Total Depreciation and Amortization (D&A)	0.44	0.68	0.82
Debt-free, Cash-free Net Working Capital to Revenue	38.26%	34.76%	25.58%
Debt-free Net Working Capital to Revenue	510.88%	265.24%	232.10%
Net Working Capital to Revenue	510.88%	265.24%	232.10%
Earnings Adjustments	-	-	-
Adjusted Basic Earnings per Share	($2.02)	($1.99)	($2.65)
Adjusted Weighted Average Basic Shares Outstanding	20.53M	20.75M	22.60M
Adjusted Diluted Earnings per Share	($2.02)	($1.99)	($2.65)
Adjusted Weighted Average Diluted Shares Outstanding	20.53M	20.75M	22.60M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	20.69M	20.93M	26.04M
Normalized Net Operating Profit after Tax (NOPAT)	-30	-30	-42
Normalized NOPAT Margin	-132.49%	-76.78%	-81.19%
Pre Tax Income Margin	-183.89%	-104.47%	-116.80%
Debt Service Ratios	-	-	-
EBIT to Interest Expense	-249.42	-21.82	-12.63
NOPAT to Interest Expense	-180.42	-16.77	-9.47
EBIT Less CapEx to Interest Expense	-253.57	-22.15	-12.93
NOPAT Less CapEx to Interest Expense	-184.57	-17.10	-9.78
Payout Ratios	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%

This table displays calculated financial ratios and metrics derived from CVRx's official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	82.21%	96.17%	95.76%	88.83%	69.92%	57.54%	34.98%	24.28%	27.23%	35.71%
EBITDA Growth	-79.59%	-1.19%	-10.47%	-0.13%	14.24%	17.80%	-92.04%	-17.07%	-43.24%	-7.01%
EBIT Growth	-78.28%	-1.91%	-11.39%	-0.80%	13.53%	17.38%	-90.88%	-17.00%	-42.75%	-7.69%
NOPAT Growth	-38.88%	-30.62%	-22.75%	-6.70%	5.91%	15.84%	-82.80%	-18.90%	-36.56%	-6.35%
Net Income Growth	-60.28%	0.32%	-13.84%	-5.24%	8.33%	13.03%	-95.06%	-20.41%	-45.37%	-16.24%
EPS Growth	-60.00%	-100.74%	-12.24%	-3.70%	10.42%	11.76%	-89.09%	-16.07%	-32.56%	13.33%
Operating Cash Flow Growth	-20.41%	-54.54%	3.71%	-26.86%	26.78%	27.69%	-6.31%	23.25%	-28.12%	-2.16%
Free Cash Flow Firm Growth	-16.67%	0.00%	-7.24%	47.54%	-13.86%	16.22%	-51.39%	33.37%	26.50%	39.92%
Invested Capital Growth	90.52%	150.40%	88.13%	131.07%	71.06%	50.01%	45.65%	5.71%	0.76%	-1.40%
Revenue Q/Q Growth	22.96%	16.00%	11.19%	19.06%	10.64%	7.55%	-4.73%	9.63%	13.26%	14.72%
EBITDA Q/Q Growth	11.70%	-5.37%	-7.36%	-0.25%	24.37%	-0.99%	-150.82%	38.89%	7.47%	24.55%
EBIT Q/Q Growth	11.31%	-5.56%	-7.32%	-0.32%	23.92%	-0.86%	-147.96%	38.51%	7.18%	23.91%
NOPAT Q/Q Growth	8.06%	-13.36%	-5.95%	3.37%	18.92%	-1.40%	-130.12%	37.15%	6.88%	21.04%
Net Income Q/Q Growth	11.21%	-7.18%	-7.95%	-2.44%	22.66%	-1.69%	-142.13%	36.77%	6.63%	18.69%
EPS Q/Q Growth	11.11%	-6.25%	-7.84%	-1.82%	23.21%	-4.65%	-131.11%	37.50%	12.31%	31.58%
Operating Cash Flow Q/Q Growth	-9.90%	2.30%	5.46%	-24.97%	36.56%	3.52%	-39.00%	9.78%	-5.90%	23.07%
Free Cash Flow Firm Q/Q Growth	63.50%	-26.05%	2.95%	-17.50%	20.78%	7.25%	-75.36%	48.29%	12.62%	24.19%
Invested Capital Q/Q Growth	42.40%	17.85%	8.74%	26.63%	5.42%	3.34%	5.59%	-8.10%	0.49%	1.12%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	78.34%	78.97%	83.36%	84.03%	83.91%	84.79%	85.00%	83.91%	83.19%	83.24%
EBITDA Margin	-156.34%	-142.00%	-137.11%	-115.44%	-78.91%	-74.09%	-195.07%	-108.74%	-88.84%	-58.42%
Operating Margin	-163.69%	-159.96%	-152.43%	-123.71%	-90.65%	-85.46%	-206.43%	-118.35%	-97.29%	-66.97%
EBIT Margin	-158.39%	-144.13%	-139.12%	-117.22%	-80.60%	-75.59%	-196.73%	-110.35%	-90.44%	-59.98%
Profit (Net Income) Margin	-158.91%	-146.82%	-142.55%	-122.64%	-85.73%	-81.05%	-206.00%	-118.82%	-97.95%	-69.42%
Tax Burden Percent	100.33%	100.27%	100.30%	100.29%	100.45%	100.43%	100.17%	100.29%	100.36%	99.34%
Interest Burden Percent	100.00%	101.60%	102.16%	104.32%	105.89%	106.78%	104.53%	107.36%	107.92%	116.52%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	-344.85%	-369.45%	-347.17%	-278.16%	-199.35%	-193.21%	-467.79%	-266.79%	-226.93%	-165.85%
ROIC Less NNEP Spread (ROIC-NNEP)	-342.75%	-367.38%	-344.57%	-274.70%	-196.73%	-190.22%	-458.33%	-259.57%	-220.26%	-159.99%
Return on Net Nonoperating Assets (RNNOA)	326.99%	347.77%	320.95%	250.41%	174.82%	165.22%	386.50%	210.29%	178.05%	128.43%
Return on Equity (ROE)	-17.85%	-21.68%	-26.22%	-27.76%	-24.52%	-27.99%	-81.30%	-56.50%	-48.88%	-37.42%
Cash Return on Invested Capital (CROIC)	0.00%	-522.98%	-447.93%	-411.05%	-333.35%	-288.00%	-323.49%	-286.85%	-291.37%	-285.83%
Operating Return on Assets (OROA)	-19.47%	-23.34%	-27.47%	-29.04%	-24.33%	-24.73%	-72.35%	-46.44%	-36.51%	-24.75%
Return on Assets (ROA)	-19.54%	-23.78%	-28.15%	-30.38%	-25.88%	-26.52%	-75.76%	-50.01%	-39.55%	-28.64%
Return on Common Equity (ROCE)	-17.85%	-21.68%	-26.22%	-27.76%	-24.52%	-27.99%	-81.30%	-56.50%	-48.88%	-37.42%
Return on Equity Simple (ROE_SIMPLE)	-35.06%	0.00%	-42.96%	-48.23%	-51.40%	0.00%	-78.49%	-98.45%	-89.71%	0.00%
Net Operating Profit after Tax (NOPAT)	-7.09	-8.04	-8.51	-8.23	-6.67	-6.76	-16	-9.78	-9.11	-7.19
NOPAT Margin	-114.58%	-111.97%	-106.70%	-86.59%	-63.45%	-59.82%	-144.50%	-82.84%	-68.11%	-46.88%
Net Nonoperating Expense Percent (NNEP)	-2.10%	-2.07%	-2.60%	-3.46%	-2.62%	-2.99%	-9.47%	-7.22%	-6.67%	-5.86%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-6.43%	-	-	-	-5.98%
Cost of Revenue to Revenue	21.66%	21.03%	16.64%	15.97%	16.09%	15.21%	15.00%	16.09%	16.81%	16.76%
SG&A Expenses to Revenue	204.96%	196.49%	192.97%	173.21%	148.91%	150.42%	263.05%	178.83%	161.76%	131.93%
R&D to Revenue	37.07%	42.45%	42.81%	34.53%	25.65%	19.82%	28.38%	23.42%	18.72%	18.28%
Operating Expenses to Revenue	242.03%	238.94%	235.78%	207.74%	174.56%	170.24%	291.43%	202.25%	180.48%	150.21%
Earnings before Interest and Taxes (EBIT)	-9.80	-10	-11	-11	-8.47	-8.55	-21	-13	-12	-9.20
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-9.67	-10	-11	-11	-8.29	-8.38	-21	-13	-12	-8.96
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.62	3.46	1.94	3.55	3.80	8.62	5.72	4.69	2.94	4.33
Price to Tangible Book Value (P/TBV)	1.62	3.46	1.94	3.55	3.80	8.62	5.72	4.69	2.94	4.33
Price to Revenue (P/Rev)	10.13	16.81	7.31	10.37	8.95	16.65	9.01	5.83	4.06	5.99
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	9.93	28.59	9.81	18.15	17.42	40.62	21.29	15.38	9.90	17.42
Enterprise Value to Revenue (EV/Rev)	4.33	12.38	3.94	7.89	7.00	15.09	7.80	4.91	2.98	4.89
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.06	0.14	0.16	0.17	0.38	0.44	0.53	0.76	0.69
Long-Term Debt to Equity	0.00	0.06	0.14	0.16	0.17	0.38	0.44	0.53	0.76	0.69
Financial Leverage	-0.95	-0.95	-0.93	-0.91	-0.89	-0.87	-0.84	-0.81	-0.81	-0.80
Leverage Ratio	1.13	1.09	1.13	1.15	1.16	1.30	1.38	1.45	1.58	1.69
Compound Leverage Factor	1.13	1.10	1.15	1.20	1.23	1.39	1.44	1.56	1.71	1.97
Debt to Total Capital	0.00%	5.82%	12.49%	13.68%	14.72%	27.79%	30.64%	34.67%	43.02%	40.95%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	5.82%	12.49%	13.68%	14.72%	27.79%	30.64%	34.67%	43.02%	40.95%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	100.00%	94.18%	87.51%	86.32%	85.28%	72.21%	69.36%	65.33%	56.98%	59.05%
Debt to EBITDA	0.00	-0.17	-0.34	-0.34	-0.35	-0.76	-0.60	-0.58	-0.91	-0.90
Net Debt to EBITDA	0.00	2.44	2.13	1.83	1.70	1.59	1.05	0.81	0.94	1.04
Long-Term Debt to EBITDA	0.00	-0.17	-0.34	-0.34	-0.35	-0.76	-0.60	-0.58	-0.91	-0.90
Debt to NOPAT	0.00	-0.23	-0.45	-0.45	-0.45	-0.97	-0.79	-0.76	-1.19	-1.18
Net Debt to NOPAT	0.00	3.34	2.84	2.40	2.18	2.03	1.37	1.06	1.24	1.36
Long-Term Debt to NOPAT	0.00	-0.23	-0.45	-0.45	-0.45	-0.97	-0.79	-0.76	-1.19	-1.18
Altman Z-Score	10.12	10.50	0.93	3.10	3.01	5.38	-0.09	-2.63	-2.81	-1.45
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	16.82	15.19	15.15	12.55	13.99	14.25	12.18	10.08	11.32	12.06
Quick Ratio	15.59	13.81	13.79	10.93	12.06	12.48	10.55	8.66	9.97	10.70
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-11	-14	-13	-16	-13	-12	-20	-11	-9.22	-6.99
Operating Cash Flow to CapEx	-4,203.03%	-13,722.78%	-4,270.42%	-8,956.64%	-20,833.33%	-4,638.46%	-1,188.22%	-2,769.01%	-28,135.14%	-15,400.00%
Free Cash Flow to Firm to Interest Expense	0.00	-84.13	-56.13	-32.91	-25.13	-20.09	-21.24	-11.00	-9.62	-4.60
Operating Cash Flow to Interest Expense	0.00	-65.70	-42.70	-26.63	-16.28	-13.54	-11.35	-10.25	-10.87	-5.27
Operating Cash Flow Less CapEx to Interest Expense	0.00	-66.18	-43.70	-26.93	-16.36	-13.83	-12.31	-10.62	-10.91	-5.30
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.12	0.16	0.20	0.25	0.30	0.33	0.37	0.42	0.40	0.41
Accounts Receivable Turnover	4.35	5.57	5.22	5.97	6.03	6.02	5.64	5.79	6.14	6.10
Inventory Turnover	0.94	0.92	0.80	0.68	0.71	0.70	0.68	0.63	0.66	0.72
Fixed Asset Turnover	14.09	14.39	15.24	17.98	20.27	22.71	19.33	19.37	21.71	24.04
Accounts Payable Turnover	4.92	4.49	2.99	3.22	5.02	3.47	2.84	2.15	3.39	3.73
Days Sales Outstanding (DSO)	83.96	65.50	69.94	61.11	60.56	60.63	64.74	63.03	59.49	59.84
Days Inventory Outstanding (DIO)	387.68	395.63	458.18	537.24	511.75	523.35	538.24	583.70	555.55	505.63
Days Payable Outstanding (DPO)	74.12	81.37	122.27	113.49	72.73	105.11	128.42	169.93	107.53	97.80
Cash Conversion Cycle (CCC)	397.52	379.75	405.86	484.86	499.58	478.87	474.56	476.80	507.51	467.68
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	8.26	9.73	11	13	14	15	15	14	14	14
Invested Capital Turnover	3.01	3.30	3.25	3.21	3.14	3.23	3.24	3.22	3.33	3.54
Increase / (Decrease) in Invested Capital	3.92	5.85	4.96	7.60	5.87	4.87	4.83	0.77	0.11	-0.21
Enterprise Value (EV)	82	278	104	243	246	593	328	218	141	251
Market Capitalization	192	378	193	320	315	654	379	259	192	307
Book Value per Share	$5.75	$5.30	$4.82	$4.34	$3.99	$3.65	$3.12	$2.56	$2.99	$2.93
Tangible Book Value per Share	$5.75	$5.30	$4.82	$4.34	$3.99	$3.65	$3.12	$2.56	$2.99	$2.93
Total Capital	118	116	114	104	97	105	96	85	114	120
Total Debt	0.00	6.75	14	14	14	29	29	29	49	49
Total Long-Term Debt	0.00	6.75	14	14	14	29	29	29	49	49
Net Debt	-110	-99	-89	-77	-69	-61	-51	-41	-51	-57
Capital Expenditures (CapEx)	0.26	0.08	0.24	0.14	0.04	0.17	0.92	0.36	0.04	0.05
Debt-free, Cash-free Net Working Capital (DFCFNWC)	7.03	8.60	9.35	12	13	14	14	12	13	13
Debt-free Net Working Capital (DFNWC)	117	115	113	103	96	104	94	83	113	119
Net Working Capital (NWC)	117	115	113	103	96	104	94	83	113	119
Net Nonoperating Expense (NNE)	2.74	2.50	2.86	3.42	2.34	2.40	6.62	4.25	3.99	3.46
Net Nonoperating Obligations (NNO)	-110	-99	-89	-77	-69	-61	-51	-41	-51	-57
Total Depreciation and Amortization (D&A)	0.13	0.15	0.16	0.17	0.18	0.17	0.18	0.19	0.21	0.24
Debt-free, Cash-free Net Working Capital to Revenue	37.10%	38.26%	35.45%	39.79%	37.53%	34.76%	32.81%	28.08%	27.01%	25.58%
Debt-free Net Working Capital to Revenue	617.47%	510.88%	427.06%	334.25%	273.53%	265.24%	223.17%	186.66%	238.97%	232.10%
Net Working Capital to Revenue	617.47%	510.88%	427.06%	334.25%	273.53%	265.24%	223.17%	186.66%	238.97%	232.10%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.48)	($0.51)	($0.55)	($0.56)	($0.43)	($0.45)	($1.04)	($0.65)	($0.57)	($0.39)
Adjusted Weighted Average Basic Shares Outstanding	20.58M	20.53M	20.69M	20.71M	20.80M	20.75M	21.23M	21.63M	22.78M	22.60M
Adjusted Diluted Earnings per Share	($0.48)	($0.51)	($0.55)	($0.56)	($0.43)	($0.45)	($1.04)	($0.65)	($0.57)	($0.39)
Adjusted Weighted Average Diluted Shares Outstanding	20.58M	20.53M	20.69M	20.71M	20.80M	20.75M	21.23M	21.63M	22.78M	22.60M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	20.58M	20.69M	20.71M	20.76M	20.82M	20.93M	21.60M	21.79M	24.26M	26.04M
Normalized Net Operating Profit after Tax (NOPAT)	-7.09	-8.04	-8.51	-8.23	-6.67	-6.76	-16	-9.78	-9.11	-7.19
Normalized NOPAT Margin	-114.58%	-111.97%	-106.70%	-86.59%	-63.45%	-59.82%	-144.50%	-82.84%	-68.11%	-46.88%
Pre Tax Income Margin	-158.39%	-146.43%	-142.12%	-122.28%	-85.35%	-80.71%	-205.65%	-118.47%	-97.60%	-69.89%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	-62.68	-46.25	-23.15	-16.98	-14.76	-22.07	-13.59	-12.62	-6.05
NOPAT to Interest Expense	0.00	-48.70	-35.47	-17.10	-13.37	-11.68	-16.21	-10.20	-9.51	-4.73
EBIT Less CapEx to Interest Expense	0.00	-63.16	-47.25	-23.45	-17.06	-15.05	-23.03	-13.96	-12.66	-6.09
NOPAT Less CapEx to Interest Expense	0.00	-49.18	-36.47	-17.40	-13.44	-11.97	-17.17	-10.57	-9.55	-4.77
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Financials Breakdown Chart

Key Financial Trends

Here are the key takeaways from CVRx, Inc. (CVRX) quarterly statements across the last four years. The focus is on trends that could impact investors.

Gross margins have remained very strong and relatively stable around the mid-80% range. Examples: Q4 2024 gross profit 12,771,000 on 15,342,000 revenue (~83.2%); Q3 2024 ~83.2%; Q2 2024 ~83.9%; Q1 2024 ~85.0%.
Total revenue has shown a long-running uptrend, rising from about 7.18 million in Q4 2022 to 15.34 million in Q4 2024, signaling meaningful top-line growth.
Liquidity remains solid with substantial cash balances across 2024 quarters (e.g., cash & equivalents around 100.2 million in Q3 2024 and ~80.1 million in Q1 2024), providing runway to fund operations.
Financing activity has provided meaningful liquidity in key periods, including substantial equity-related inflows (Q3 2024 net cash from continuing financing activities +$40.2 million; Q4 2024 +$13.8 million; Q1 2024 +$7.57 million).
Earnings per share show improvement within 2024 (diluted EPS narrowed to -$0.39 in Q4 2024 from -$1.04 in Q1 2024), evidencing some progress in per-share losses even as overall profitability remains negative.
Dilution risk exists, as weighted-average shares outstanding increased notably (Q3 2024 roughly 24.26 million; Q4 2024 roughly 26.04 million), signaling ongoing equity issuance and dilution for existing holders.
Long-term debt rose through 2024 (e.g., about $29.3 million in Q2 2024 to $49.2 million in Q3 2024), suggesting higher leverage but still modest relative to reported equity in the period.
Operating cash flow remains negative in every quarter, though the magnitude fluctuates (Q4 2024 net cash from continuing operating activities -$8.01 million; Q3 2024 -$10.41 million; Q2 2024 -$9.83 million; Q1 2024 -$10.90 million).
Net income is consistently negative across the period, indicating ongoing losses (Q4 2024: -$10.65 million; Q3 2024: -$13.10 million; Q2 2024: -$14.03 million; Q1 2024: -$22.17 million).
Total operating income remains negative in all recent quarters (Q4 2024: -$10.27 million; Q3 2024: -$13.01 million), reflecting operating inefficiency despite solid gross margins.
Retained earnings are deeply negative and have been increasing as losses accumulate (e.g., Q1 2024 retained earnings around -$499.6 million; Q3 2024 around -$526.7 million), signaling a long-running cumulative loss discipline and an equity-heavy balance sheet reliance.

05/19/26 01:38 PM ETAI Generated. May Contain Errors.

CVRx Financials - Frequently Asked Questions

According to the most recent income statement we have on file, CVRx's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

CVRx's net income appears to be on an upward trend, with a most recent value of -$59.97 million in 2024, rising from -$41.43 million in 2022. The previous period was -$41.20 million in 2023. Check out CVRx's forecast to explore projected trends and price targets.

CVRx's total operating income in 2024 was -$59.49 million, based on the following breakdown:

Total Gross Profit: $42.96 million
Total Operating Expenses: $102.45 million

Over the last 2 years, CVRx's total revenue changed from $22.47 million in 2022 to $51.29 million in 2024, a change of 128.3%.

CVRx's total liabilities were at $62.36 million at the end of 2024, a 58.7% increase from 2023, and a 295.8% increase since 2022.

In the past 2 years, CVRx's cash and equivalents has ranged from $90.57 million in 2023 to $106.19 million in 2022, and is currently $105.93 million as of their latest financial filing in 2024.

Over the last 2 years, CVRx's book value per share changed from 5.30 in 2022 to 2.93 in 2024, a change of -44.8%.

Related Companies

Financial statements for NASDAQ:CVRX last updated on 4/6/2025 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

CVRx (CVRX) Financials

Financials Breakdown Chart

Key Financial Trends

CVRx Financials - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

CVRx (CVRX) Financials

Annual Income Statements for CVRx

Quarterly Income Statements for CVRx

Annual Cash Flow Statements for CVRx

Quarterly Cash Flow Statements for CVRx

Annual Balance Sheets for CVRx

Quarterly Balance Sheets for CVRx

Annual Metrics And Ratios for CVRx

Quarterly Metrics And Ratios for CVRx

Financials Breakdown Chart

Key Financial Trends

CVRx Financials - Frequently Asked Questions

When does CVRx's financial year end?

How has CVRx's net income changed over the last 2 years?

What is CVRx's operating income?

How has CVRx's revenue changed over the last 2 years?

How much debt does CVRx have?

How much cash does CVRx have?

How has CVRx's book value per share changed over the last 2 years?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools